Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

CP-461 for the Treatment of Crohn's Disease

ClinicalTrials.gov ID: NCT00042055

Public ClinicalTrials.gov record NCT00042055. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Pilot Study of CP-461 in the Treatment of Moderately to Severely Active Crohn's Disease

Study identification

NCT ID
NCT00042055
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
30 participants

Conditions and interventions

Interventions

  • CP-461 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2002
Primary completion
Not listed
Completion
Aug 31, 2003
Last update posted
Oct 16, 2011

2002 – 2003

United States locations

U.S. sites
10
U.S. states
10
U.S. cities
10
Facility City State ZIP Site status
Southern Drug Research Birmingham Alabama 35211
Community Clinical Trials Orange California 92868
Florida Medical Research Institute, PA Gainesville Florida 32607
Atlanta Gastroenterology Associates Atlanta Georgia 30342
University of Chicago Medical Center Chicago Illinois 60637
Indianapolis Gastroenterology and Hepatology, Inc. Indianapolis Indiana 46237
Digestive Disease Associates, PA Columbia Maryland 21044
Atlantic Gastroenterology Associates Egg Harbor New Jersey 08234
Long Island Clinical Research Associates, LLP Great Neck New York 11021
Consultants for Clinical Research, Inc. Cincinnati Ohio 95219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00042055, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2011 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00042055 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →